SG11201507277YA - Modification and novel compositions of human secretoglobin proteins - Google Patents
Modification and novel compositions of human secretoglobin proteinsInfo
- Publication number
- SG11201507277YA SG11201507277YA SG11201507277YA SG11201507277YA SG11201507277YA SG 11201507277Y A SG11201507277Y A SG 11201507277YA SG 11201507277Y A SG11201507277Y A SG 11201507277YA SG 11201507277Y A SG11201507277Y A SG 11201507277YA SG 11201507277Y A SG11201507277Y A SG 11201507277YA
- Authority
- SG
- Singapore
- Prior art keywords
- modification
- novel compositions
- human
- proteins
- secretoglobin proteins
- Prior art date
Links
- 102000011274 Secretoglobin Human genes 0.000 title 1
- 108050001520 Secretoglobin Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/843,773 US9394349B2 (en) | 2013-03-15 | 2013-03-15 | Modification and compositions of human secretoglobin proteins |
| PCT/US2014/030117 WO2014145368A2 (en) | 2013-03-15 | 2014-03-17 | Modification and novel compositions of human secretoglobin proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507277YA true SG11201507277YA (en) | 2015-10-29 |
Family
ID=51530119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507277YA SG11201507277YA (en) | 2013-03-15 | 2014-03-17 | Modification and novel compositions of human secretoglobin proteins |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9394349B2 (enExample) |
| EP (2) | EP2968449A4 (enExample) |
| JP (2) | JP6670987B2 (enExample) |
| KR (1) | KR20160030076A (enExample) |
| CN (1) | CN105744946A (enExample) |
| AU (1) | AU2014233127A1 (enExample) |
| BR (1) | BR112015021266A2 (enExample) |
| CA (1) | CA2907439A1 (enExample) |
| IL (1) | IL241417A0 (enExample) |
| MX (1) | MX2015013092A (enExample) |
| RU (1) | RU2015144360A (enExample) |
| SG (1) | SG11201507277YA (enExample) |
| WO (1) | WO2014145368A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9394349B2 (en) * | 2013-03-15 | 2016-07-19 | Therabron Therapeutics, Inc. | Modification and compositions of human secretoglobin proteins |
| US12162914B2 (en) | 2013-03-15 | 2024-12-10 | Apc Research Assets Llc | Modification and compositions of human secretoglobin proteins |
| US20180112200A1 (en) * | 2014-12-22 | 2018-04-26 | The Regents Of The University Of California | Compositions and methods for generating antigens, antibodies, and immunotherapeutic compositions and methods |
| JP6827113B2 (ja) | 2017-01-21 | 2021-02-10 | 広州白雲山漢方現代薬業有限公司Ｇｕａｎｇｚｈｏｕ Ｈａｎｆａｎｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．，Ｌｔｄ． | シェーグレン症候群の治療におけるペオニフロリン−６’−ｏ−ベンゼンスルホン酸の使用 |
| JP2022509856A (ja) * | 2018-11-30 | 2022-01-24 | エーピーシー リサーチ アセッツ，エルエルシー | ヘパラン硫酸プロテオグリカンタンパク質との相互作用を介してグリコカリックスを保護するためのセクレトグロビンの組成物及び使用方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1006919A3 (nl) * | 1993-03-15 | 1995-01-24 | Ley Marc Jozef Philemon De | Farmaceutisch preparaat op basis van clara celeiwit cc10, en het gebruik daarvan als geneesmiddel en diagnosticum. |
| US20060281681A1 (en) | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| US20030008816A1 (en) | 1997-05-28 | 2003-01-09 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20040047857A1 (en) * | 1997-05-28 | 2004-03-11 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| AU5551299A (en) | 1998-08-13 | 2000-03-06 | Trustees Of The University Of Pennsylvania, The | Method of identifying proteins |
| US6953666B1 (en) | 1998-11-06 | 2005-10-11 | Emory University | Biomarkers for oxidative stress |
| WO2004101824A1 (ja) | 2003-05-14 | 2004-11-25 | Shionogi & Co., Ltd. | 慢性閉塞性肺疾患の検出方法 |
| AU2004254600A1 (en) | 2003-06-26 | 2005-01-13 | Lifesensors, Inc. | Methods and compositions for enhanced protein expression and purification |
| CN1580261A (zh) * | 2003-08-06 | 2005-02-16 | 上海富纯中南生物技术有限公司 | Cc10蛋白的制备及应用 |
| US7318936B2 (en) | 2003-11-14 | 2008-01-15 | Alza Corporation | Minimization of drug oxidation in drug irradiated excipients formulations |
| US20060275794A1 (en) | 2005-03-07 | 2006-12-07 | Invitrogen Corporation | Collections of matched biological reagents and methods for identifying matched reagents |
| WO2008039941A2 (en) | 2006-09-27 | 2008-04-03 | The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services | Scgb3a2 as a growth factor and anti-apoptotic agent |
| US20090004684A1 (en) | 2007-05-23 | 2009-01-01 | Claudia Susanne Maier | Compositions and Methods for Detection and Quantification of Protein Oxidation |
| EP2488205B1 (en) * | 2009-10-15 | 2016-09-21 | Clarassance, Inc. | Recombinant human cc10 protein for treatment of influenza |
| US9394349B2 (en) * | 2013-03-15 | 2016-07-19 | Therabron Therapeutics, Inc. | Modification and compositions of human secretoglobin proteins |
-
2013
- 2013-03-15 US US13/843,773 patent/US9394349B2/en active Active
-
2014
- 2014-03-17 RU RU2015144360A patent/RU2015144360A/ru unknown
- 2014-03-17 MX MX2015013092A patent/MX2015013092A/es unknown
- 2014-03-17 EP EP14765106.1A patent/EP2968449A4/en not_active Withdrawn
- 2014-03-17 CN CN201480015618.3A patent/CN105744946A/zh active Pending
- 2014-03-17 BR BR112015021266A patent/BR112015021266A2/pt not_active IP Right Cessation
- 2014-03-17 CA CA2907439A patent/CA2907439A1/en not_active Abandoned
- 2014-03-17 EP EP18167516.6A patent/EP3403666A1/en active Pending
- 2014-03-17 AU AU2014233127A patent/AU2014233127A1/en not_active Abandoned
- 2014-03-17 WO PCT/US2014/030117 patent/WO2014145368A2/en not_active Ceased
- 2014-03-17 KR KR1020157029582A patent/KR20160030076A/ko not_active Ceased
- 2014-03-17 SG SG11201507277YA patent/SG11201507277YA/en unknown
- 2014-03-17 JP JP2016503333A patent/JP6670987B2/ja active Active
-
2015
- 2015-09-09 IL IL241417A patent/IL241417A0/en unknown
-
2016
- 2016-07-17 US US15/212,277 patent/US10294285B2/en active Active
-
2019
- 2019-05-20 US US16/416,268 patent/US10676513B2/en active Active
- 2019-12-02 JP JP2019218277A patent/JP2020055833A/ja active Pending
-
2020
- 2020-06-09 US US16/896,213 patent/US20200325190A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL241417A0 (en) | 2015-11-30 |
| US20160362462A1 (en) | 2016-12-15 |
| EP2968449A4 (en) | 2017-03-22 |
| CA2907439A1 (en) | 2014-09-18 |
| US20200325190A1 (en) | 2020-10-15 |
| KR20160030076A (ko) | 2016-03-16 |
| EP3403666A1 (en) | 2018-11-21 |
| BR112015021266A2 (pt) | 2017-10-10 |
| US9394349B2 (en) | 2016-07-19 |
| US10676513B2 (en) | 2020-06-09 |
| JP2020055833A (ja) | 2020-04-09 |
| US20190337999A1 (en) | 2019-11-07 |
| US20140275477A1 (en) | 2014-09-18 |
| WO2014145368A3 (en) | 2014-11-27 |
| CN105744946A (zh) | 2016-07-06 |
| JP2016515532A (ja) | 2016-05-30 |
| WO2014145368A2 (en) | 2014-09-18 |
| RU2015144360A (ru) | 2017-04-24 |
| EP2968449A2 (en) | 2016-01-20 |
| MX2015013092A (es) | 2016-06-02 |
| US10294285B2 (en) | 2019-05-21 |
| JP6670987B2 (ja) | 2020-03-25 |
| AU2014233127A1 (en) | 2015-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276106A (en) | Garp-binding proteins and their uses | |
| EP2970508A4 (en) | GENETICALLY MODIFIED LOADING ANTIBODIES OR ENHANCED ENHANCEMENT ENHANCEMENT TARGETING PROTEIN COMPOSITIONS AND METHODS OF USE | |
| ZA201603308B (en) | Novel anti-claudin antibodies and methods of use | |
| IL245946A0 (en) | Anti-dpep3 antibodies and methods of use | |
| IL265876A (en) | Preparations that include 15-ohepa and methods of using them | |
| EP2970490A4 (en) | Antibodies to mica and micb proteins | |
| SG11201509136YA (en) | Cenicriviroc compositions and methods of making and using the same | |
| ZA201505966B (en) | Peptides and compositions | |
| PT2986633T (pt) | Métodos para a expressão de proteínas e peptídeos | |
| HUE044392T2 (hu) | Immunoglobulin egyváltozós domének stabil készítményei és azok alkalmazásai | |
| IL241418A0 (en) | Improved methods of use for recombinant human secretoglobins | |
| IL241417A0 (en) | Modification and new compositions of human scartoglobin proteins | |
| GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same | |
| IL241248A0 (en) | Enhanced expression of pico-rnavirus proteins | |
| ZA201602304B (en) | Modified anti-inflammatory proteins and method of use | |
| EP2978770A4 (en) | REINFORCEMENT OF PROTEINS | |
| GB201321911D0 (en) | N-Glycosylation of peptides and proteins | |
| GB201318313D0 (en) | N-Glycosylation of peptides and proteins | |
| GB201300628D0 (en) | Compositions comprising 15-OHEPA and methods of using the same | |
| GB201310349D0 (en) | Composition and method of use thereof | |
| GB201301928D0 (en) | Composition and method of use thereof |